首页> 美国卫生研究院文献>other >Lessons Learned From Option B+ in the Evolution Toward Test and Start From Malawi Cameroon and the United Republic of Tanzania
【2h】

Lessons Learned From Option B+ in the Evolution Toward Test and Start From Malawi Cameroon and the United Republic of Tanzania

机译:从选项B +到马拉维喀麦隆和坦桑尼亚联合共和国的测试与开始演变过程中吸取的教训

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The acceleration of prevention of mother-to-child transmission (PMTCT) activities, coupled with the rollout of 2010 World Health Organization (WHO) guidelines, led to important discussions and innovations at global and country levels. One paradigm-shifting innovation was Option B+ in Malawi. It was later included in WHO guidelines and eventually adopted by all 22 Global Plan priority countries. This article presents Malawi’s experience with designing and implementing Option B+ and provides complementary narratives from Cameroon and Tanzania. Malawi’s HIV program started in 2002, but by 2009, the PMTCT program was lagging far behind the antiretroviral therapy (ART) program because of numerous health system challenges. When WHO recommended Option A and Option B for PMTCT in 2010, it was clear that Malawi’s HIV program would not be able to successfully implement either option without increasing existing barriers to PMTCT services and potentially decreasing women’s access to care. Subsequent stake-holder discussions led to the development of Option B+. Operationalizing Option B+ required several critical considerations, including the complete integration of ART and PMTCT programs, systematic reduction of barriers to facilitate doubling the number of ART sites in less than a year, building consensus with stakeholders, and securing additional resources for the new program. During the planning and implementation process, several lessons were learned which are considerations for countries transitioning to “treat-all”: Comprehensive change requires effective government leadership and coordination; national clinical guidelines must accommodate health system limitations; ART services and commodities should be decentralized within facilities; the general public should be well informed about major changes in the national HIV program; and patients should be educated on clinic processes to improve program monitoring.
机译:预防母婴传播(PMTCT)活动的加速,加上2010年世界卫生组织(WHO)准则的推出,导致了全球和国家层面的重要讨论和创新。一种改变范式的创新是马拉维的Option B +。后来将其纳入世卫组织指南,并最终为所有22个全球计划优先国家所采用。本文介绍了马拉维在设计和实施方案B +方面的经验,并提供了喀麦隆和坦桑尼亚的补充说明。马拉维的艾滋病毒计划始于2002年,但到2009年,由于许多卫生系统的挑战,PMTCT计划远远落后于抗逆转录病毒疗法(ART)计划。当世卫组织在2010年为PMTCT建议方案A和方案B时,很明显,如果不增加PMTCT服务的现有障碍并可能减少妇女获得护理的机会,马拉维的艾滋病项目将无法成功实施这两种方案。随后的利益相关者讨论导致了方案B +的开发。使方案B +投入运营需要几个关键的考虑因素,包括将ART和PMTCT计划完全整合,有系统地减少障碍以促进在不到一年的时间内将ART地点数量增加一倍,与利益相关者达成共识以及为新计划获取更多资源。在规划和实施过程中,吸取了一些教训,这是过渡到“全力以赴”的国家的考虑因素:全面变革需要有效的政府领导和协调;国家临床指南必须适应卫生系统的限制; ART服务和商品应在设施内下放;应向公众充分通报国家艾滋病毒计划的重大变化;并且应该对患者的临床过程进行教育,以改善程序监控。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号